Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
C-RAD and Accuray Sign Agreement to Enhance Radixact® System Breast Cancer Treatment Capabilities
C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed […]
Enhertu Granted Breakthrough Therapy Designation in US for Patients with HER2-positive Metastatic Breast Cancer Treated with One or More Prior Anti-HER2-based Regimens
The Food and Drug Administration (FDA) has granted Enhertu (trastuzumab deruxtecan), Breakthrough Therapy Designation (BTD) in the […]
CTI BioPharma Announces Topline Data from Final Analysis of the PRE-VENT Clinical Trial Evaluating Pacritinib as a Treatment for Severe COVID-19
CTI BioPharma Corp. (Nasdaq: CTIC) today announced topline results from the PRE-VENT trial (NCT04404361) of pacritinib […]
CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments & Expand Activity in China
CoreBone, a company that produces bioactive, coral-based bone graft material, announced that it has completed an […]
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the latest additions to […]
Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to […]
NHS Sets Out Next Stage of Covid Recovery Plan
Guidance to support hospitals with covid recovery over the next six months has been set […]
Bio-Rad Launches IgA and IgM SARS-CoV-2 Bio-Plex Pro Immunoassay Panels to Study COVID-19 Antibody Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]
New Study Finds Freenome ’s Multiomics Approach Successful in Detecting Pancreatic Cancer
Freenome, a privately-held biotech company, presented new research today at the American Association of Cancer […]
A*STAR and Local SME Work with Vaccination Centres to Deploy Automated Systems for Filling Syringes
The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more